Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Gene therapy results in neuroprotection, functional regeneration in primate PD model

Nov. 7, 2000

New Knoll compound useful for seizures, neurological disorders and neurological damage

Nov. 6, 2000

SB researchers discover series of rodent anti-human IL-18 antibodies

Nov. 6, 2000

New heterocyclic compounds from Shionogi with affinity for 5-HT receptors

Nov. 6, 2000

Acorda awarded two NIH grants for CNS repair research

Nov. 6, 2000

Axonyx actively pursues development of AD treatments, diagnostics

Nov. 6, 2000

Tachykinin antagonists from Merck claimed for pain, etc.

Nov. 3, 2000

Abbott to transfer Gabitril rights to Cephalon

Nov. 3, 2000

Lanicemine now claimed for treatment of headache

Nov. 2, 2000

Pharmacia files NDA for injectable parecoxib sodium

Nov. 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...